Novavax, Inc.
CH ˙ SWX ˙ US6700024010
SecurityCH:NVAX / Novavax, Inc.
InstitutionIMC-Chicago, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
IMC-Chicago, LLC ownership in NVAX / Novavax, Inc.

On May 5, 2026 - IMC-Chicago, LLC filed a 13F-HR form disclosing ownership of 0 shares of Novavax, Inc. (CH:NVAX) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 78,083 shares of Novavax, Inc.. This represents a change in shares of -100.00% during the quarter.

IMC-Chicago, LLC has a history of taking positions in derivatives of the underlying security (NVAX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 248,100 of underlying shares valued at $2,019,534 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CH:NVAX / Novavax, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F NOVAVAX COM NEW 670002401 0 -78,083 -100.00 0 -100.00
2026-01-29 2025-12-31 13F NOVAVAX COM NEW 670002401 78,083 78,083 525 0.0002
2025-11-04 2025-09-30 13F NOVAVAX COM NEW 670002401 0 -61,793 -100.00 0 -100.00
2025-07-22 2025-06-30 13F NOVAVAX COM NEW 670002401 61,793 17,329 38.97 389 36.49 0.0002
2025-04-14 2025-03-31 13F NOVAVAX COM NEW 670002401 44,464 44,464 285 0.0002
2024-07-15 2024-06-30 13F NOVAVAX COM NEW 670002401 0 -68,322 -100.00 0 -100.00
2024-04-12 2024-03-31 13F NOVAVAX COM NEW 670002401 68,322 16,671 32.28 327 31.98 0.0002
2024-02-09 2023-12-31 13F NOVAVAX COM NEW 670002401 51,651 51,651 248 0.0002
2022-08-05 2022-06-30 13F NOVAVAX COM NEW 670002401 0 -41,853 -100.00 0 -100.00
2022-04-19 2022-03-31 13F NOVAVAX COM NEW 670002401 41,853 5,212 14.22 3,082 -41.21 0.0030
2022-02-08 2021-12-31 13F NOVAVAX COM NEW 670002401 36,641 -16,745 -31.37 5,242 -52.63 0.0044
2021-11-05 2021-09-30 13F NOVAVAX COM NEW 670002401 53,386 53,386 11,067 0.0116
2021-08-06 2021-06-30 13F NOVAVAX COM NEW 670002401 0 -14,087 -100.00 0 -100.00
2021-05-14 2021-03-31 13F NOVAVAX COM NEW 670002401 14,087 14,087 2,554 0.0037
2020-11-16 2020-09-30 13F NOVAVAX COM NEW 670002401 0 -15,106 -100.00 0 -100.00
2020-08-14 2020-06-30 13F NOVAVAX COM NEW 670002401 15,106 15,106 1,259 0.0026
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-02-07 2021-12-31 13F NOVAVAX COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-05 2021-09-30 13F NOVAVAX COM NEW Call 323,500 67,065 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F NOVAVAX COM NEW Put 248,100 -33.68 2,020 -19.66 n/a n/a n/a
2026-01-29 2025-12-31 13F NOVAVAX COM NEW Put 374,100 -12.53 2,514 -32.23 n/a n/a n/a
2025-11-04 2025-09-30 13F NOVAVAX COM NEW Put 427,700 -20.91 3,708 8.83 n/a n/a n/a
2025-07-22 2025-06-30 13F NOVAVAX COM NEW Put 540,800 116.49 3,407 112.80 n/a n/a n/a
2025-04-14 2025-03-31 13F NOVAVAX COM NEW Put 249,800 170.35 1,601 115.77 n/a n/a n/a
2025-01-27 2024-12-31 13F NOVAVAX COM NEW Put 92,400 -51.34 743 -69.06 n/a n/a n/a
2024-10-25 2024-09-30 13F NOVAVAX COM NEW Put 189,900 -12.29 2,398 -12.48 n/a n/a n/a
2024-07-15 2024-06-30 13F NOVAVAX COM NEW Put 216,500 84.10 2,741 387.54 n/a n/a n/a
2024-04-12 2024-03-31 13F NOVAVAX COM NEW Put 117,600 -52.83 562 -53.01 n/a n/a n/a
2024-02-09 2023-12-31 13F NOVAVAX COM NEW Put 249,300 -8.68 1,197 -39.47 n/a n/a n/a
2023-10-12 2023-09-30 13F NOVAVAX COM NEW Put 273,000 16.97 1,977 13.96 n/a n/a n/a
2023-07-14 2023-06-30 13F NOVAVAX COM NEW Put 233,400 -59.20 1,734 -56.25 n/a n/a n/a
2023-04-24 2023-03-31 13F NOVAVAX COM NEW Put 572,000 13.27 3,964 -23.66 n/a n/a n/a
2023-04-24 2022-12-31 13F/A NOVAVAX COM NEW Put 505,000 16.47 5,191 -34.22 n/a n/a n/a
2023-02-09 2022-12-31 13F NOVAVAX COM NEW Put 505,000 5 n/a n/a n/a
2022-11-08 2022-09-30 13F NOVAVAX COM NEW Put 433,600 35.46 7,892 -52.06 n/a n/a n/a
2022-08-05 2022-06-30 13F NOVAVAX COM NEW Put 320,100 -41.97 16,463 -59.48 n/a n/a n/a
2022-04-19 2022-03-31 13F NOVAVAX COM NEW Put 551,600 -14.65 40,625 -56.06 n/a n/a n/a
2022-02-08 2021-12-31 13F NOVAVAX COM NEW Put 646,300 76.06 92,466 21.50 n/a n/a n/a
2021-11-05 2021-09-30 13F NOVAVAX COM NEW Put 367,100 1.72 76,104 -0.68 n/a n/a n/a
2021-08-06 2021-06-30 13F NOVAVAX COM NEW Put 360,900 41.97 76,623 66.25 n/a n/a n/a
2021-05-14 2021-03-31 13F NOVAVAX COM NEW Put 254,200 5.78 46,089 72.00 n/a n/a n/a
2021-02-17 2020-12-31 13F NOVAVAX COM NEW Put 240,300 -42.74 26,796 -41.07 n/a n/a n/a
2020-11-17 2020-09-30 13F NOVAVAX COM NEW Put 419,700 163.30 45,474 242.27 n/a n/a n/a
2020-08-14 2020-06-30 13F NOVAVAX COM NEW Put 159,400 13,286 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.